🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Primary Objective: * To describe the safety profile of the SP MenB vaccine...
Status
Terminated
Location
Lakeview Clinical Research Site Number : 8400029
Start Date
2021-03-29
Trial ID
NCT04825223
Treatments Being Tested
This study will determine whether participants who receive the vaccine V419...
Status
Completed
Location
Multiple Locations
Start Date
2011-05-26
Trial ID
NCT01341639
Treatments Being Tested
The objective of this study is to evaluate the safety, tolerability and imm...
Status
Unknown
Location
Al Kuwait Hospital (Al Baraha Hospital)
Start Date
2021-12-22
Trial ID
NCT05043311
The study is planned as a single-center, randomized, double-blind placebo-c...
Status
Completed
Location
Multiple Locations
Start Date
2013-08
Trial ID
NCT02538185
The purpose of this study is to determine whether long-acting octreotide is...
Status
Unknown
Location
Radboudumc
Start Date
2016-10
Trial ID
NCT02874326
Treatments Being Tested
To study signals of efficacy and safety of a currently available dosage for...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-03-04
Trial ID
NCT04561180
Treatments Being Tested
The primary purpose of this study is to determine whether HepavaxGene TF is...
Status
Completed
Location
Center for Disease Control and Prevention Jiangsu Province
Start Date
2011-05
Trial ID
NCT01349283
Treatments Being Tested
This is an 8-week, double-blind, randomized placebo-controlled trial of the...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2023-04-18
Trial ID
NCT05262270
The aim of this clinical trial is to explore the efficacy of fatty acid and...
Status
Not Yet Recruiting
Location
Tsinghua University
Start Date
2025-02
Trial ID
NCT06827873
This study is designed to 1) describe the safety, tolerability, and immunog...
Status
Completed
Location
Bliss Healthcare Services ( Site 0010)
Start Date
2018-07-06
Trial ID
NCT03480802
Treatments Being Tested